img

Global Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Antibodies market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Antibodies include Novartis, F. Hoffmann-La Roche, Johnson & Johnson Services, Amgen, Bristol-Myers Squibb, AbbVie and Eli Lilly, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Antibodies, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Antibodies by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Antibodies market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Antibodies market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Novartis
F. Hoffmann-La Roche
Johnson & Johnson Services
Amgen
Bristol-Myers Squibb
AbbVie
Eli Lilly
By Type
Monoclonal antibodies
Polyclonal antibodies
Antibody drug conjugates
By Application
Hospitals
Long-term care facilities
Research institutes
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Antibodies in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Antibodies manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibodies sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Antibodies Definition
1.2 Market by Type
1.2.1 Global Antibodies Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Monoclonal antibodies
1.2.3 Polyclonal antibodies
1.2.4 Antibody drug conjugates
1.3 Market Segment by Application
1.3.1 Global Antibodies Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospitals
1.3.3 Long-term care facilities
1.3.4 Research institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Antibodies Sales
2.1 Global Antibodies Revenue Estimates and Forecasts 2018-2034
2.2 Global Antibodies Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Antibodies Revenue by Region
2.3.1 Global Antibodies Revenue by Region (2018-2023)
2.3.2 Global Antibodies Revenue by Region (2024-2034)
2.4 Global Antibodies Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Antibodies Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Antibodies Sales Quantity by Region
2.6.1 Global Antibodies Sales Quantity by Region (2018-2023)
2.6.2 Global Antibodies Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Antibodies Sales Quantity by Manufacturers
3.1.1 Global Antibodies Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Antibodies Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Antibodies Sales in 2024
3.2 Global Antibodies Revenue by Manufacturers
3.2.1 Global Antibodies Revenue by Manufacturers (2018-2023)
3.2.2 Global Antibodies Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Antibodies Revenue in 2024
3.3 Global Antibodies Sales Price by Manufacturers
3.4 Global Key Players of Antibodies, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antibodies, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antibodies, Product Offered and Application
3.8 Global Key Manufacturers of Antibodies, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Antibodies Sales Quantity by Type
4.1.1 Global Antibodies Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Antibodies Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Antibodies Sales Quantity Market Share by Type (2018-2034)
4.2 Global Antibodies Revenue by Type
4.2.1 Global Antibodies Historical Revenue by Type (2018-2023)
4.2.2 Global Antibodies Forecasted Revenue by Type (2024-2034)
4.2.3 Global Antibodies Revenue Market Share by Type (2018-2034)
4.3 Global Antibodies Price by Type
4.3.1 Global Antibodies Price by Type (2018-2023)
4.3.2 Global Antibodies Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Antibodies Sales Quantity by Application
5.1.1 Global Antibodies Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Antibodies Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Antibodies Sales Quantity Market Share by Application (2018-2034)
5.2 Global Antibodies Revenue by Application
5.2.1 Global Antibodies Historical Revenue by Application (2018-2023)
5.2.2 Global Antibodies Forecasted Revenue by Application (2024-2034)
5.2.3 Global Antibodies Revenue Market Share by Application (2018-2034)
5.3 Global Antibodies Price by Application
5.3.1 Global Antibodies Price by Application (2018-2023)
5.3.2 Global Antibodies Price Forecast by Application (2024-2034)
6 North America
6.1 North America Antibodies Sales by Company
6.1.1 North America Antibodies Revenue by Company (2018-2023)
6.1.2 North America Antibodies Sales Quantity by Company (2018-2023)
6.2 North America Antibodies Market Size by Type
6.2.1 North America Antibodies Sales Quantity by Type (2018-2034)
6.2.2 North America Antibodies Revenue by Type (2018-2034)
6.3 North America Antibodies Market Size by Application
6.3.1 North America Antibodies Sales Quantity by Application (2018-2034)
6.3.2 North America Antibodies Revenue by Application (2018-2034)
6.4 North America Antibodies Market Size by Country
6.4.1 North America Antibodies Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Antibodies Revenue by Country (2018-2034)
6.4.3 North America Antibodies Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Antibodies Sales by Company
7.1.1 Europe Antibodies Sales Quantity by Company (2018-2023)
7.1.2 Europe Antibodies Revenue by Company (2018-2023)
7.2 Europe Antibodies Market Size by Type
7.2.1 Europe Antibodies Sales Quantity by Type (2018-2034)
7.2.2 Europe Antibodies Revenue by Type (2018-2034)
7.3 Europe Antibodies Market Size by Application
7.3.1 Europe Antibodies Sales Quantity by Application (2018-2034)
7.3.2 Europe Antibodies Revenue by Application (2018-2034)
7.4 Europe Antibodies Market Size by Country
7.4.1 Europe Antibodies Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Antibodies Revenue by Country (2018-2034)
7.4.3 Europe Antibodies Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Antibodies Sales by Company
8.1.1 China Antibodies Sales Quantity by Company (2018-2023)
8.1.2 China Antibodies Revenue by Company (2018-2023)
8.2 China Antibodies Market Size by Type
8.2.1 China Antibodies Sales Quantity by Type (2018-2034)
8.2.2 China Antibodies Revenue by Type (2018-2034)
8.3 China Antibodies Market Size by Application
8.3.1 China Antibodies Sales Quantity by Application (2018-2034)
8.3.2 China Antibodies Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Antibodies Sales by Company
9.1.1 APAC Antibodies Sales Quantity by Company (2018-2023)
9.1.2 APAC Antibodies Revenue by Company (2018-2023)
9.2 APAC Antibodies Market Size by Type
9.2.1 APAC Antibodies Sales Quantity by Type (2018-2034)
9.2.2 APAC Antibodies Revenue by Type (2018-2034)
9.3 APAC Antibodies Market Size by Application
9.3.1 APAC Antibodies Sales Quantity by Application (2018-2034)
9.3.2 APAC Antibodies Revenue by Application (2018-2034)
9.4 APAC Antibodies Market Size by Region
9.4.1 APAC Antibodies Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Antibodies Revenue by Region (2018-2034)
9.4.3 APAC Antibodies Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antibodies Sales by Company
10.1.1 Middle East, Africa and Latin America Antibodies Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Antibodies Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Antibodies Market Size by Type
10.2.1 Middle East, Africa and Latin America Antibodies Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Antibodies Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Antibodies Market Size by Application
10.3.1 Middle East, Africa and Latin America Antibodies Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Antibodies Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Antibodies Market Size by Country
10.4.1 Middle East, Africa and Latin America Antibodies Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Antibodies Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Antibodies Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Novartis Antibodies Products and Services
11.1.5 Novartis Antibodies SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Overview
11.2.3 F. Hoffmann-La Roche Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 F. Hoffmann-La Roche Antibodies Products and Services
11.2.5 F. Hoffmann-La Roche Antibodies SWOT Analysis
11.2.6 F. Hoffmann-La Roche Recent Developments
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Company Information
11.3.2 Johnson & Johnson Services Overview
11.3.3 Johnson & Johnson Services Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Johnson & Johnson Services Antibodies Products and Services
11.3.5 Johnson & Johnson Services Antibodies SWOT Analysis
11.3.6 Johnson & Johnson Services Recent Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Overview
11.4.3 Amgen Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Amgen Antibodies Products and Services
11.4.5 Amgen Antibodies SWOT Analysis
11.4.6 Amgen Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Overview
11.5.3 Bristol-Myers Squibb Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Bristol-Myers Squibb Antibodies Products and Services
11.5.5 Bristol-Myers Squibb Antibodies SWOT Analysis
11.5.6 Bristol-Myers Squibb Recent Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Overview
11.6.3 AbbVie Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 AbbVie Antibodies Products and Services
11.6.5 AbbVie Antibodies SWOT Analysis
11.6.6 AbbVie Recent Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Company Information
11.7.2 Eli Lilly Overview
11.7.3 Eli Lilly Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Eli Lilly Antibodies Products and Services
11.7.5 Eli Lilly Antibodies SWOT Analysis
11.7.6 Eli Lilly Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Antibodies Value Chain Analysis
12.2 Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibodies Production Mode & Process
12.4 Antibodies Sales and Marketing
12.4.1 Antibodies Sales Channels
12.4.2 Antibodies Distributors
12.5 Antibodies Customers
13 Market Dynamics
13.1 Antibodies Industry Trends
13.2 Antibodies Market Drivers
13.3 Antibodies Market Challenges
13.4 Antibodies Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antibodies Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Monoclonal antibodies
Table 3. Major Manufacturers of Polyclonal antibodies
Table 4. Major Manufacturers of Antibody drug conjugates
Table 5. Global Antibodies Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Antibodies Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Antibodies Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Antibodies Revenue Market Share by Region (2018-2023)
Table 9. Global Antibodies Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Antibodies Revenue Market Share by Region (2024-2034)
Table 11. Global Antibodies Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 12. Global Antibodies Sales by Region (2018-2023) & (K Units)
Table 13. Global Antibodies Sales Market Share by Region (2018-2023)
Table 14. Global Antibodies Sales by Region (2024-2034) & (K Units)
Table 15. Global Antibodies Sales Market Share by Region (2024-2034)
Table 16. Global Antibodies Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 17. Global Antibodies Sales Quantity Share by Manufacturers (2018-2023)
Table 18. Global Antibodies Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Antibodies Revenue Share by Manufacturers (2018-2023)
Table 20. Global Antibodies Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Key Players of Antibodies, Industry Ranking, 2021 VS 2024
Table 22. Global Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibodies as of 2024)
Table 24. Global Key Manufacturers of Antibodies, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Antibodies, Product Offered and Application
Table 26. Global Key Manufacturers of Antibodies, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Antibodies Sales Quantity by Type (2018-2023) & (K Units)
Table 29. Global Antibodies Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Antibodies Sales Quantity Share by Type (2018-2023)
Table 31. Global Antibodies Sales Quantity Share by Type (2024-2034)
Table 32. Global Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Antibodies Revenue Share by Type (2018-2023)
Table 35. Global Antibodies Revenue Share by Type (2024-2034)
Table 36. Antibodies Price by Type (2018-2023) & (USD/Unit)
Table 37. Global Antibodies Price Forecast by Type (2024-2034) & (USD/Unit)
Table 38. Global Antibodies Sales Quantity by Application (2018-2023) & (K Units)
Table 39. Global Antibodies Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Antibodies Sales Quantity Share by Application (2018-2023)
Table 41. Global Antibodies Sales Quantity Share by Application (2024-2034)
Table 42. Global Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Antibodies Revenue Share by Application (2018-2023)
Table 45. Global Antibodies Revenue Share by Application (2024-2034)
Table 46. Antibodies Price by Application (2018-2023) & (USD/Unit)
Table 47. Global Antibodies Price Forecast by Application (2024-2034) & (USD/Unit)
Table 48. North America Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 49. North America Antibodies Sales Quantity by Company (2018-2023) & (K Units)
Table 50. North America Antibodies Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Antibodies Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 53. North America Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Antibodies Sales Quantity by Application (2018-2023) & (K Units)
Table 55. North America Antibodies Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 57. North America Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Antibodies Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 59. North America Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 60. North America Antibodies Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Antibodies Sales Quantity by Country (2018-2023) & (K Units)
Table 62. North America Antibodies Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Antibodies Sales Quantity by Company (2018-2023) & (K Units)
Table 64. Europe Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 65. Europe Antibodies Sales Quantity by Type (2018-2023) & (K Units)
Table 66. Europe Antibodies Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Antibodies Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Europe Antibodies Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Antibodies Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 74. Europe Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Antibodies Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Antibodies Sales Quantity by Country (2018-2023) & (K Units)
Table 77. Europe Antibodies Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Antibodies Sales Quantity by Company (2018-2023) & (K Units)
Table 79. China Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 80. China Antibodies Sales Quantity by Type (2018-2023) & (K Units)
Table 81. China Antibodies Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Antibodies Sales Quantity by Application (2018-2023) & (K Units)
Table 85. China Antibodies Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Antibodies Sales Quantity by Company (2018-2023) & (K Units)
Table 89. APAC Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 90. APAC Antibodies Sales Quantity by Type (2018-2023) & (K Units)
Table 91. APAC Antibodies Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 93. APAC Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Antibodies Sales Quantity by Application (2018-2023) & (K Units)
Table 95. APAC Antibodies Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 97. APAC Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Antibodies Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 99. APAC Antibodies Revenue by Region (2018-2023) & (US$ Million)
Table 100. APAC Antibodies Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Antibodies Sales Quantity by Region (2018-2023) & (K Units)
Table 102. APAC Antibodies Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Antibodies Sales Quantity by Company (2018-2023) & (K Units)
Table 104. Middle East, Africa and Latin America Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Antibodies Sales Quantity by Type (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Antibodies Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Antibodies Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America Antibodies Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Antibodies Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Antibodies Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Antibodies Sales Quantity by Country (2018-2023) & (K Units)
Table 117. Middle East, Africa and Latin America Antibodies Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Novartis Company Information
Table 119. Novartis Description and Overview
Table 120. Novartis Antibodies Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 121. Novartis Antibodies Product and Services
Table 122. Novartis Antibodies SWOT Analysis
Table 123. Novartis Recent Developments
Table 124. F. Hoffmann-La Roche Company Information
Table 125. F. Hoffmann-La Roche Description and Overview
Table 126. F. Hoffmann-La Roche Antibodies Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 127. F. Hoffmann-La Roche Antibodies Product and Services
Table 128. F. Hoffmann-La Roche Antibodies SWOT Analysis
Table 129. F. Hoffmann-La Roche Recent Developments
Table 130. Johnson & Johnson Services Company Information
Table 131. Johnson & Johnson Services Description and Overview
Table 132. Johnson & Johnson Services Antibodies Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 133. Johnson & Johnson Services Antibodies Product and Services
Table 134. Johnson & Johnson Services Antibodies SWOT Analysis
Table 135. Johnson & Johnson Services Recent Developments
Table 136. Amgen Company Information
Table 137. Amgen Description and Overview
Table 138. Amgen Antibodies Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 139. Amgen Antibodies Product and Services
Table 140. Amgen Antibodies SWOT Analysis
Table 141. Amgen Recent Developments
Table 142. Bristol-Myers Squibb Company Information
Table 143. Bristol-Myers Squibb Description and Overview
Table 144. Bristol-Myers Squibb Antibodies Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 145. Bristol-Myers Squibb Antibodies Product and Services
Table 146. Bristol-Myers Squibb Antibodies SWOT Analysis
Table 147. Bristol-Myers Squibb Recent Developments
Table 148. AbbVie Company Information
Table 149. AbbVie Description and Overview
Table 150. AbbVie Antibodies Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 151. AbbVie Antibodies Product and Services
Table 152. AbbVie Antibodies SWOT Analysis
Table 153. AbbVie Recent Developments
Table 154. Eli Lilly Company Information
Table 155. Eli Lilly Description and Overview
Table 156. Eli Lilly Antibodies Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 157. Eli Lilly Antibodies Product and Services
Table 158. Eli Lilly Antibodies SWOT Analysis
Table 159. Eli Lilly Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Antibodies Distributors List
Table 163. Antibodies Customers List
Table 164. Antibodies Market Trends
Table 165. Antibodies Market Drivers
Table 166. Antibodies Market Challenges
Table 167. Antibodies Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibodies Product Picture
Figure 2. Global Antibodies Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Antibodies Market Share by Type in 2024 & 2034
Figure 4. Monoclonal antibodies Product Picture
Figure 5. Polyclonal antibodies Product Picture
Figure 6. Antibody drug conjugates Product Picture
Figure 7. Global Antibodies Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global Antibodies Market Share by Application in 2024 & 2034
Figure 9. Hospitals
Figure 10. Long-term care facilities
Figure 11. Research institutes
Figure 12. Antibodies Report Years Considered
Figure 13. Global Antibodies Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Antibodies Revenue 2018-2034 (US$ Million)
Figure 15. Global Antibodies Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Antibodies Sales Quantity 2018-2034 (K Units)
Figure 17. Global Antibodies Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Antibodies Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Antibodies Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. North America Antibodies Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Antibodies Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. Europe Antibodies Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Antibodies Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. China Antibodies Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Antibodies Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. APAC Antibodies Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Antibodies Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Antibodies Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Antibodies Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Antibodies Revenue in 2024
Figure 31. Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Antibodies Revenue Market Share by Type (2018-2034)
Figure 34. Global Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Antibodies Revenue Market Share by Application (2018-2034)
Figure 36. North America Antibodies Revenue Market Share by Company in 2024
Figure 37. North America Antibodies Sales Quantity Market Share by Company in 2024
Figure 38. North America Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Antibodies Revenue Market Share by Type (2018-2034)
Figure 40. North America Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Antibodies Revenue Market Share by Application (2018-2034)
Figure 42. North America Antibodies Revenue Share by Country (2018-2034)
Figure 43. North America Antibodies Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Antibodies Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Antibodies Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Antibodies Sales Quantity Market Share by Company in 2024
Figure 47. Europe Antibodies Revenue Market Share by Company in 2024
Figure 48. Europe Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Antibodies Revenue Market Share by Type (2018-2034)
Figure 50. Europe Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Antibodies Revenue Market Share by Application (2018-2034)
Figure 52. Europe Antibodies Revenue Share by Country (2018-2034)
Figure 53. Europe Antibodies Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Antibodies Revenue (2018-2034) & (US$ Million)
Figure 55. France Antibodies Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Antibodies Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Antibodies Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Antibodies Revenue (2018-2034) & (US$ Million)
Figure 59. China Antibodies Sales Quantity Market Share by Company in 2024
Figure 60. China Antibodies Revenue Market Share by Company in 2024
Figure 61. China Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Antibodies Revenue Market Share by Type (2018-2034)
Figure 63. China Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Antibodies Revenue Market Share by Application (2018-2034)
Figure 65. APAC Antibodies Sales Quantity Market Share by Company in 2024
Figure 66. APAC Antibodies Revenue Market Share by Company in 2024
Figure 67. APAC Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Antibodies Revenue Market Share by Type (2018-2034)
Figure 69. APAC Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Antibodies Revenue Market Share by Application (2018-2034)
Figure 71. APAC Antibodies Revenue Share by Region (2018-2034)
Figure 72. APAC Antibodies Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Antibodies Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Antibodies Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Antibodies Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Antibodies Revenue (2018-2034) & (US$ Million)
Figure 77. India Antibodies Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Antibodies Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Antibodies Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Antibodies Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Antibodies Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Antibodies Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Antibodies Revenue Share by Country (2018-2034)
Figure 86. Brazil Antibodies Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Antibodies Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Antibodies Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Antibodies Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Antibodies Revenue (2018-2034) & (US$ Million)
Figure 91. Antibodies Value Chain
Figure 92. Antibodies Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries